News & Media

Joint Resolution Calls on the State’s Public Health System and Providers to Use BMI 23 When Screening Asian Americans for Diabetes Boston, MA – (January 22, 2018) – Legislators from both the...

A new paper co-authored by Joslin’s CMO Robert A. Gabbay, MD, PhD finds administration of life-saving medicine not in scope of practice for EMTs Boston, MA—(January 16, 2018) — For people with...

Genetic analysis links the hormone GLP-1 with cardiovascular mortality risks. BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing...

Studies in mice show that fructose plays a more damaging role than glucose in fatty liver disease and help to explain why. BOSTON – (October 3, 2017) – If you’re one of the two billion people in the...

Research in mice highlights protective mechanism that lowers chronic inflammation leading toward cardiovascular disease. BOSTON – (September 20, 2017) – In type 2 diabetes, chronic inflammation drives...

Alliance will provide expertise and training for new diabetes center in Nanjing, China Boston, Ma. – (September 18, 2017) – Joslin Diabetes Center, the world’s preeminent diabetes care and research...

Boston – (September 18, 2017) – George L. King, MD, Senior Vice President and Chief Scientific Officer of Joslin Diabetes Center received the Founders Choice Award during GK50, an event celebrating...

Better management is linked to lower risks of cardiovascular disease, the leading cause of death in this population. BOSTON – (July 26, 2017) – “People are living longer with type 1 diabetes, and the...

Boston – (July 1, 2017) - Joslin Diabetes Center, the preeminent institution for diabetes research and care, affiliated with Harvard Medical, has been awarded $8.2 million from the National Institutes...

Boston - (June 12, 2017) – The JDRF has awarded Lloyd Paul Aiello, M.D., Ph.D., the 2017 JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award. The announcement was made...

Children’s Mercy Kansas City and Joslin Diabetes Center announce project with Cyft technology to apply predictive analytics to proactively identify and manage at-risk individuals June 9, 2017 –...

BOSTON, MA (June 8, 2017) – Researchers and clinicians at Joslin Diabetes Center have established a Center for Cell-Based Therapy for Diabetes (CCTD), the goal of which is to lead the development and...

Animal studies examine risk factors that may overlap between colorectal cancer and cardiovascular disease. BOSTON – (May 1, 2017) – Over the decades, scientists have repeatedly shown that patients...

Study of Joslin Medalists suggests a novel treatment approach that may protect against dangerous complications. BOSTON – (April 24, 2017) – More than 660,000 people in the United States suffer from...

BOSTON – (April 18, 2017) - Researchers from Joslin Diabetes Center have developed a prognostic tool that accurately predicts the risk of end stage renal disease (ESRD) in patients with both type 1...